Press Releases AlzeCure Pharma AB

Equities

ALZCUR

SE0010133785

Market Closed - Nasdaq Stockholm Other stock markets 11:29:57 2024-06-05 am EDT			5-day change	1st Jan Change
2.02 ^SEK	+1.25%		+3.06%	-35.05%

May. 14	AlzeCure Pharma AB Approves the Election of Jan Lundberg as New Ordinary Members of the Board of Directors	CI
May. 13	AlzeCure Pharma AB Reports Anti-Inflammatory Effects with NeuroRestore ACD856 with Relevance to Alzheimer's Leading to New Patent Application	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AlzeCure Pharma AB - Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg elected as a new board member	May. 16	AQ
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg elected as a new board member	May. 15	AQ
Communiqué from the annual general meeting of AlzeCure Pharma on 14 May 2024	May. 14	AQ
AlzeCure reports anti-inflammatory effects with NeuroRestore ACD856 with relevance to Alzheimer's leading to new patent application	May. 13	AQ
AlzeCure Pharma publishes prospectus	Apr. 29	AQ
AlzeCure publishes its interim report for January – March 2024	Apr. 25	AQ
Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board	Apr. 10	AQ
AlzeCure Pharma publishes its Annual Report for 2023	Apr. 04	AQ
AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024	Apr. 03	AQ
AlzeCure to partake in Redeye Theme, Alzheimer on March 21	Mar. 15	AQ
AlzeCure to partake in Redeye Theme: Alzheimer on March 21	Mar. 14	AQ
AlzeCure presents new preclinical data with NeuroRestore ACD856 at leading Alzheimer's conference	Mar. 07	AQ
AlzeCure publishes clinical results supporting continued development of NeuroRestore ACD856 against Alzheimer's	Mar. 05	AQ
AlzeCure's Alzheimer's project NeuroRestore ACD856 is granted an additional patent	Feb. 29	AQ
AlzeCure publishes its Year-end report for January – December 2023	Feb. 27	AQ
AlzeCure Pharma broadcasts live expert event on Alzheimer's around highly current gamma-secretase modulators	Feb. 12	AQ
AlzeCure gets Late Breaking abstract of new preclinical data with ACD856 accepted at AD/PD 2024 conference	Feb. 06	AQ
AlzeCure CEO Martin Jonsson to present at the international investor conference BioCapitalEurope	Feb. 01	AQ
AlzeCure CEO Martin Jönsson to present at the international investor conference BioCapitalEurope	Jan. 31	AQ
AlzeCure selects drug candidate and enters next phase of development with TrkA-NAM ACD137 against severe pain	Jan. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AlzeCure Pharma AB

Equities

ALZCUR

SE0010133785

Press Releases

Filters